Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2020 Mar 12;8(7):2234–2242. doi: 10.1016/j.jaip.2020.03.003

Table 4.

Studies evaluating critical inhaler steps for MDIs as defined by lung deposition or disease control

Preparatory step Affects drug delivery Affects symptoms or disease control

Inhaler step

 Expose mouthpiece/remove cap

 Cannister shaken (if medication in suspension) Everard (1995)9

If first use or if several days have elapsed since last use, prime inhaler by releasing actuations into the air Dewsbury (1996)30
Kenyon (1998)32
Janssens (1999)36
Mitchell (2007)35

 Head tilted so that chin is slightly upward

 Hold inhaler upright Price (2017)56*

 Exhale before actuating inhaler Hindle (1993)90

 Does not exhale into inhaler Price (2017)56*

 Actuate inhaler at the start of inhalation Newman (1991)91 Price (2017)56
Farr (1995)92

Inhalation takes place over 3–5 seconds, or slow and deep inhalation Al-Showair (2007)102
Newman (1980)93
Newman (1981)94
Dolovich (1981)95
Newman (1982)96
Lawford (1983)97
Hindle (1993)90
Newman (1995)98
Pavia (1995)99
Farr (1995)92
Heyder (2004)100
Tomlinson (2005)101

Hold breath for 5–10 seconds Newman (1980)93
Newman (1982)96
Hindle (1993)90

 Correct second dose preparation and timing Price (2017)56

 Replace cap after use
*

study combined the errors “exhaled into the inhaler or did not hold inhaler upright”

study combined the errors “lack of device knowledge or incorrect second dose preparation, timing or inhalation”